| pubmed-article:1671211 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1671211 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:1671211 | lifeskim:mentions | umls-concept:C0027662 | lld:lifeskim |
| pubmed-article:1671211 | lifeskim:mentions | umls-concept:C0878544 | lld:lifeskim |
| pubmed-article:1671211 | lifeskim:mentions | umls-concept:C0205462 | lld:lifeskim |
| pubmed-article:1671211 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:1671211 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1671211 | pubmed:dateCreated | 1991-3-7 | lld:pubmed |
| pubmed-article:1671211 | pubmed:abstractText | A catecholamine-induced dilated cardiomyopathy is reported in a patient with multiple endocrine neoplasia, type 3. A histologic and ultrastructural study has been undertaken in cardiac biopsy samples, together with determination of myocardial Ca++ and cellular membrane fatty acids. Contraction band necrosis of cardiocytes with supercontraction of sarcomeres progressing to myofibrolysis and increased levels of myocardial Ca++ have been found as morphologic and biochemical abnormalities, respectively. No lipoperoxidation of cellular membranes or an alpha-adrenergic mediated reduction of coronary supply could be recognized in the study. We indicate a receptor-mediated intracellular Ca++ overload as the main abnormality responsible for myocardial impairment. | lld:pubmed |
| pubmed-article:1671211 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671211 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1671211 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671211 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:1671211 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671211 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671211 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671211 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1671211 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:1671211 | pubmed:issn | 0012-3692 | lld:pubmed |
| pubmed-article:1671211 | pubmed:author | pubmed-author:GentiloniNN | lld:pubmed |
| pubmed-article:1671211 | pubmed:author | pubmed-author:LoperfidoFF | lld:pubmed |
| pubmed-article:1671211 | pubmed:author | pubmed-author:RussoM AMA | lld:pubmed |
| pubmed-article:1671211 | pubmed:author | pubmed-author:FrustaciAA | lld:pubmed |
| pubmed-article:1671211 | pubmed:author | pubmed-author:CaldaruloMM | lld:pubmed |
| pubmed-article:1671211 | pubmed:author | pubmed-author:MorgantiII | lld:pubmed |
| pubmed-article:1671211 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1671211 | pubmed:volume | 99 | lld:pubmed |
| pubmed-article:1671211 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1671211 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1671211 | pubmed:pagination | 382-5 | lld:pubmed |
| pubmed-article:1671211 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:meshHeading | pubmed-meshheading:1671211-... | lld:pubmed |
| pubmed-article:1671211 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1671211 | pubmed:articleTitle | Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study. | lld:pubmed |
| pubmed-article:1671211 | pubmed:affiliation | Institute of Cardiology and Internal Medicine, Catholic University, Rome, Italy. | lld:pubmed |
| pubmed-article:1671211 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1671211 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671211 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671211 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671211 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671211 | lld:pubmed |
